Cargando…
Short-term adverse remodeling progression in asymptomatic aortic stenosis
OBJECTIVES: Aortic stenosis (AS) is characterised by a long and variable asymptomatic course. Our objective was to use cardiovascular magnetic resonance imaging (MRI) to assess progression of adverse remodeling in asymptomatic AS. METHODS: Participants from the PRIMID-AS study, a prospective, multi-...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8128853/ https://www.ncbi.nlm.nih.gov/pubmed/33215248 http://dx.doi.org/10.1007/s00330-020-07462-9 |
_version_ | 1783694183484096512 |
---|---|
author | Singh, Anvesha Chan, Daniel C. S. Kanagala, Prathap Hogrefe, Kai Kelly, Damian J. Khoo, Jeffery P. Sprigings, David Greenwood, John P. Abdelaty, Ahmed M. S. E. K. Jerosch-Herold, Michael Ng, Leong L. McCann, Gerry P. |
author_facet | Singh, Anvesha Chan, Daniel C. S. Kanagala, Prathap Hogrefe, Kai Kelly, Damian J. Khoo, Jeffery P. Sprigings, David Greenwood, John P. Abdelaty, Ahmed M. S. E. K. Jerosch-Herold, Michael Ng, Leong L. McCann, Gerry P. |
author_sort | Singh, Anvesha |
collection | PubMed |
description | OBJECTIVES: Aortic stenosis (AS) is characterised by a long and variable asymptomatic course. Our objective was to use cardiovascular magnetic resonance imaging (MRI) to assess progression of adverse remodeling in asymptomatic AS. METHODS: Participants from the PRIMID-AS study, a prospective, multi-centre observational study of asymptomatic patients with moderate to severe AS, who remained asymptomatic at 12 months, were invited to undergo a repeat cardiac MRI. RESULTS: Forty-three participants with moderate-severe AS (mean age 64.4 ± 14.8 years, 83.4% male, aortic valve area index 0.54 ± 0.15 cm(2)/m(2)) were included. There was small but significant increase in indexed left ventricular (LV) (90.7 ± 22.0 to 94.5 ± 23.1 ml/m(2), p = 0.007) and left atrial volumes (52.9 ± 11.3 to 58.6 ± 13.6 ml/m(2), p < 0.001), with a decrease in systolic (LV ejection fraction 57.9 ± 4.6 to 55.6 ± 4.1%, p = 0.001) and diastolic (longitudinal diastolic strain rate 1.06 ± 0.2 to 0.99 ± 0.2 1/s, p = 0.026) function, but no overall change in LV mass or mass/volume. Late gadolinium enhancement increased (2.02 to 4.26 g, p < 0.001) but markers of diffuse interstitial fibrosis did not change significantly (extracellular volume index 12.9 [11.4, 17.0] ml/m(2) to 13.3 [11.1, 15.1] ml/m(2), p = 0.689). There was also a significant increase in the levels of NT-proBNP (43.6 [13.45, 137.08] pg/ml to 53.4 [19.14, 202.20] pg/ml, p = 0.001). CONCLUSIONS: There is progression in cardiac remodeling with increasing scar burden even in asymptomatic AS. Given the lack of reversibility of LGE post-AVR and its association with long-term mortality post-AVR, this suggests the potential need for earlier intervention, before the accumulation of LGE, to improve the long-term outcomes in AS. KEY POINTS: • Current guidelines recommend waiting until symptom onset before valve replacement in severe AS. • MRI showed clear progression in cardiac remodeling over 12 months in asymptomatic patients with AS, with near doubling in LGE. • This highlights the need for potentially earlier intervention or better risk stratification in AS. |
format | Online Article Text |
id | pubmed-8128853 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Springer Berlin Heidelberg |
record_format | MEDLINE/PubMed |
spelling | pubmed-81288532021-05-24 Short-term adverse remodeling progression in asymptomatic aortic stenosis Singh, Anvesha Chan, Daniel C. S. Kanagala, Prathap Hogrefe, Kai Kelly, Damian J. Khoo, Jeffery P. Sprigings, David Greenwood, John P. Abdelaty, Ahmed M. S. E. K. Jerosch-Herold, Michael Ng, Leong L. McCann, Gerry P. Eur Radiol Cardiac OBJECTIVES: Aortic stenosis (AS) is characterised by a long and variable asymptomatic course. Our objective was to use cardiovascular magnetic resonance imaging (MRI) to assess progression of adverse remodeling in asymptomatic AS. METHODS: Participants from the PRIMID-AS study, a prospective, multi-centre observational study of asymptomatic patients with moderate to severe AS, who remained asymptomatic at 12 months, were invited to undergo a repeat cardiac MRI. RESULTS: Forty-three participants with moderate-severe AS (mean age 64.4 ± 14.8 years, 83.4% male, aortic valve area index 0.54 ± 0.15 cm(2)/m(2)) were included. There was small but significant increase in indexed left ventricular (LV) (90.7 ± 22.0 to 94.5 ± 23.1 ml/m(2), p = 0.007) and left atrial volumes (52.9 ± 11.3 to 58.6 ± 13.6 ml/m(2), p < 0.001), with a decrease in systolic (LV ejection fraction 57.9 ± 4.6 to 55.6 ± 4.1%, p = 0.001) and diastolic (longitudinal diastolic strain rate 1.06 ± 0.2 to 0.99 ± 0.2 1/s, p = 0.026) function, but no overall change in LV mass or mass/volume. Late gadolinium enhancement increased (2.02 to 4.26 g, p < 0.001) but markers of diffuse interstitial fibrosis did not change significantly (extracellular volume index 12.9 [11.4, 17.0] ml/m(2) to 13.3 [11.1, 15.1] ml/m(2), p = 0.689). There was also a significant increase in the levels of NT-proBNP (43.6 [13.45, 137.08] pg/ml to 53.4 [19.14, 202.20] pg/ml, p = 0.001). CONCLUSIONS: There is progression in cardiac remodeling with increasing scar burden even in asymptomatic AS. Given the lack of reversibility of LGE post-AVR and its association with long-term mortality post-AVR, this suggests the potential need for earlier intervention, before the accumulation of LGE, to improve the long-term outcomes in AS. KEY POINTS: • Current guidelines recommend waiting until symptom onset before valve replacement in severe AS. • MRI showed clear progression in cardiac remodeling over 12 months in asymptomatic patients with AS, with near doubling in LGE. • This highlights the need for potentially earlier intervention or better risk stratification in AS. Springer Berlin Heidelberg 2020-11-19 2021 /pmc/articles/PMC8128853/ /pubmed/33215248 http://dx.doi.org/10.1007/s00330-020-07462-9 Text en © The Author(s) 2020 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Cardiac Singh, Anvesha Chan, Daniel C. S. Kanagala, Prathap Hogrefe, Kai Kelly, Damian J. Khoo, Jeffery P. Sprigings, David Greenwood, John P. Abdelaty, Ahmed M. S. E. K. Jerosch-Herold, Michael Ng, Leong L. McCann, Gerry P. Short-term adverse remodeling progression in asymptomatic aortic stenosis |
title | Short-term adverse remodeling progression in asymptomatic aortic stenosis |
title_full | Short-term adverse remodeling progression in asymptomatic aortic stenosis |
title_fullStr | Short-term adverse remodeling progression in asymptomatic aortic stenosis |
title_full_unstemmed | Short-term adverse remodeling progression in asymptomatic aortic stenosis |
title_short | Short-term adverse remodeling progression in asymptomatic aortic stenosis |
title_sort | short-term adverse remodeling progression in asymptomatic aortic stenosis |
topic | Cardiac |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8128853/ https://www.ncbi.nlm.nih.gov/pubmed/33215248 http://dx.doi.org/10.1007/s00330-020-07462-9 |
work_keys_str_mv | AT singhanvesha shorttermadverseremodelingprogressioninasymptomaticaorticstenosis AT chandanielcs shorttermadverseremodelingprogressioninasymptomaticaorticstenosis AT kanagalaprathap shorttermadverseremodelingprogressioninasymptomaticaorticstenosis AT hogrefekai shorttermadverseremodelingprogressioninasymptomaticaorticstenosis AT kellydamianj shorttermadverseremodelingprogressioninasymptomaticaorticstenosis AT khoojefferyp shorttermadverseremodelingprogressioninasymptomaticaorticstenosis AT sprigingsdavid shorttermadverseremodelingprogressioninasymptomaticaorticstenosis AT greenwoodjohnp shorttermadverseremodelingprogressioninasymptomaticaorticstenosis AT abdelatyahmedmsek shorttermadverseremodelingprogressioninasymptomaticaorticstenosis AT jeroschheroldmichael shorttermadverseremodelingprogressioninasymptomaticaorticstenosis AT ngleongl shorttermadverseremodelingprogressioninasymptomaticaorticstenosis AT mccanngerryp shorttermadverseremodelingprogressioninasymptomaticaorticstenosis |